Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
Alk-Abello Price to Book Value: 7.711 for Sept. 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2024 | 7.711 |
| September 16, 2024 | 7.711 |
| September 13, 2024 | 7.711 |
| September 12, 2024 | 7.711 |
| September 11, 2024 | 7.711 |
| September 10, 2024 | 7.711 |
| September 09, 2024 | 7.711 |
| September 06, 2024 | 7.711 |
| September 05, 2024 | 7.711 |
| September 04, 2024 | 6.795 |
| September 03, 2024 | 6.795 |
| August 30, 2024 | 6.795 |
| August 29, 2024 | 6.795 |
| August 28, 2024 | 6.795 |
| August 27, 2024 | 6.795 |
| August 26, 2024 | 6.795 |
| August 23, 2024 | 6.795 |
| August 22, 2024 | 6.795 |
| August 21, 2024 | 6.795 |
| August 20, 2024 | 6.795 |
| August 19, 2024 | 6.795 |
| August 16, 2024 | 6.795 |
| August 15, 2024 | 6.795 |
| August 14, 2024 | 6.795 |
| August 13, 2024 | 6.795 |
| Date | Value |
|---|---|
| August 12, 2024 | 6.795 |
| August 09, 2024 | 6.795 |
| August 08, 2024 | 6.795 |
| August 07, 2024 | 6.795 |
| August 06, 2024 | 6.795 |
| August 05, 2024 | 6.795 |
| August 02, 2024 | 6.795 |
| August 01, 2024 | 6.795 |
| July 31, 2024 | 6.795 |
| July 30, 2024 | 6.795 |
| July 29, 2024 | 6.795 |
| July 26, 2024 | 6.795 |
| July 25, 2024 | 6.896 |
| July 24, 2024 | 6.896 |
| July 23, 2024 | 6.896 |
| July 22, 2024 | 6.896 |
| July 19, 2024 | 6.896 |
| July 18, 2024 | 6.896 |
| July 17, 2024 | 6.896 |
| July 16, 2024 | 6.896 |
| July 15, 2024 | 6.896 |
| July 12, 2024 | 6.896 |
| July 11, 2024 | 6.896 |
| July 10, 2024 | 6.896 |
| July 09, 2024 | 6.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.152
Minimum
Jul 07 2023
10.87
Maximum
Dec 27 2021
6.315
Average
5.941
Median
Jan 15 2020
Price to Book Value Benchmarks
| Genmab AS | 3.743 |
| Ascendis Pharma AS | -- |
| Galecto Inc | 0.6367 |
| Evaxion Biotech AS | 13.48 |
| IO Biotech Inc | 0.9033 |
Price to Book Value Related Metrics
| PE Ratio | 54.70 |
| PS Ratio | 7.405 |
| PEG Ratio | 0.4987 |
| Price to Free Cash Flow | 53.07 |
| Price | 24.60 |
| Earnings Yield | 1.83% |
| Market Cap | 5.445B |
| PEGY Ratio | 0.4987 |
| Operating PE Ratio | 41.64 |
| Normalized PE Ratio | 54.70 |